These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 7770741

  • 1. Assessment of the central dopaminergic index of plasma HVA in schizophrenia.
    Amin F, Davidson M, Kahn RS, Schmeidler J, Stern R, Knott PJ, Apter S.
    Schizophr Bull; 1995; 21(1):53-66. PubMed ID: 7770741
    [Abstract] [Full Text] [Related]

  • 2. Assessment of brain dopamine metabolism from plasma HVA and MHPG during debrisoquin treatment: validation in monkeys treated with MPTP.
    Kopin IJ, Bankiewicz KS, Harvey-White J.
    Neuropsychopharmacology; 1988 May; 1(2):119-25. PubMed ID: 3266957
    [Abstract] [Full Text] [Related]

  • 3. Psychotic patients with increased plasma HVA and MHPG or increased HVA alone.
    Bowers MB.
    Biol Psychiatry; 1993 Oct 15; 34(8):584-6. PubMed ID: 8274591
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dopamine metabolism and disposition in schizophrenic patients. Studies using debrisoquin.
    Maas JW, Contreras SA, Seleshi E, Bowden CL.
    Arch Gen Psychiatry; 1988 Jun 15; 45(6):553-9. PubMed ID: 3377641
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Lithium in combination with perphenazine: effect on plasma monoamine metabolites.
    Bowers MB, Mazure CM, Nelson JC, Jatlow PI.
    Biol Psychiatry; 1992 Dec 15; 32(12):1102-7. PubMed ID: 1477190
    [Abstract] [Full Text] [Related]

  • 8. Plasma homovanillic acid as an index of central dopaminergic activity: studies in schizophrenic patients.
    Pickar D, Breier A, Kelsoe J.
    Ann N Y Acad Sci; 1988 Dec 15; 537():339-46. PubMed ID: 2904783
    [Abstract] [Full Text] [Related]

  • 9. Plasma homovanillic acid and performance on motor and cognitive tasks in community-dwelling elderly: MacArthur studies of successful aging.
    Amin F, Seeman TE, Mohs RC, Davidson M, Knott P, Berkman LF, Albert M, Blazer D.
    Neuropsychopharmacology; 1994 Feb 15; 10(1):29-35. PubMed ID: 8179792
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Direct determination of homovanillic acid release from the human brain, an indicator of central dopaminergic activity.
    Lambert GW, Eisenhofer G, Cox HS, Horne M, Kalff V, Kelly M, Jennings GL, Esler MD.
    Life Sci; 1991 Feb 15; 49(15):1061-72. PubMed ID: 1895870
    [Abstract] [Full Text] [Related]

  • 12. Relationship between plasma and cerebrospinal fluid norepinephrine and dopamine metabolites in a nonhuman primate.
    Greene KA, Faull KF.
    J Neurochem; 1989 Oct 15; 53(4):1007-13. PubMed ID: 2769251
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The acute effects of central- and peripheral-acting dopamine antagonists on plasma HVA in schizophrenic patients.
    Konicki PE, Owen RR, Litman RE, Pickar D.
    Life Sci; 1991 Oct 15; 48(14):1411-6. PubMed ID: 2008157
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Plasma catecholamine metabolites and early response to haloperidol.
    Bowers MB, Swigar ME, Jatlow PI, Goicoechea N.
    J Clin Psychiatry; 1984 Jun 15; 45(6):248-51. PubMed ID: 6725216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.